Which is the most established rationale for molecular and biomarker analysis in patients with PCa?
a) To help define treatment choices and clinical trial options
b) To help diagnose cancer in other family members.
c) To aid in management of any other type of cancer the patient might have.
d) To provide diagnostic results in lieu of biopsy.